Benralizumab 30 MG/ML [Fasenra] clinical trials

Interest of a Targeted Therapy for the Treatment of a Severe Form of Hypersensitivity to Drug (DRESS Syndrome)

This study looks into a new treatment for DRESS syndrome, a severe drug allergy. It aims to see if adding a drug called benralizumab to usual care can help patients recover faster and reduce hospital stays by targeting certain immune cells.